An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19. The work also underscores ...
Mar 24, 2021
0
141
Influenza A viruses spawn epidemics, global pandemics and sweeping outbreaks that kill millions of birds, yet only now have flu scientists obtained comprehensive, high-resolution structural data on a protein that is key to ...
It's often said that the HIV/AIDS epidemic has a woman's face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with disease. ...
Sep 27, 2013
3
0
SARS-CoV-2, the respiratory virus that causes COVID-19, attacks the body in multiple steps. Gaining entry into cells deep within the lungs and hijacking the human host cell's machinery to churn out copies of itself are two ...
Nov 6, 2020
0
200
While the focus has been largely on vaccines, you might have also heard Pfizer is trialing a pill to treat COVID-19.
Jun 1, 2021
0
4
(HealthDay)—There's growing evidence that the herpes virus responsible for cold sores also may cause Alzheimer's disease, a new research paper contends.
Oct 19, 2018
0
10
The billions of immune cells that help protect us from diseases do amazing things, but sometimes they need a little boost. For decades, scientists have been trying to figure out ways to engineer living immune cells to better ...
Sep 10, 2022
0
147
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down ...
May 10, 2023
0
82
The number of people infected with the new coronavirus continues to skyrocket, with more than 80,000 cases worldwide as of the end of February. But there's no vaccine or cure in sight, meaning that doctors can do little more ...
Feb 27, 2020
1
321
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
